GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,933.80INR
5:27am EST
Price Change (% chg)

Rs0.10 (--)
Prev Close
Rs2,933.70
Open
Rs2,949.00
Day's High
Rs2,966.95
Day's Low
Rs2,920.10
Volume
9,786
Avg. Vol
22,214
52-wk High
Rs3,054.50
52-wk Low
Rs2,365.00

GLAX.NS

Chart for GLAX.NS

About

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company’s product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, cardiovascular disease and respiratory diseases. It also offers... (more)

Overall

Beta: 0.20
Market Cap (Mil.): Rs248,493.20
Shares Outstanding (Mil.): 84.70
Dividend: 50.00
Yield (%): 1.70

Financials

  GLAX.NS Industry Sector
P/E (TTM): 75.86 37.69 38.55
EPS (TTM): 38.67 -- --
ROI: -- 17.92 17.25
ROE: -- 18.73 18.17
Search Stocks

CORRECTED-BRIEF-Galapagos says GSK2586184 will not be developed by GSK for oral administration in psoriasis

* GlaxoSmithKline (GSK) (Not GlaxoSmithKline Pharmaceuticals (GSK) ) has informed Galapagos that GSK2586184, a selective JAK1 inhibitor licensed from Galapagos, will not be developed by GSK for oral administration in psoriasis

06 Nov 2014

Exclusive - India likely to extend price caps to more drugs: sources

MUMBAI - India is likely to raise the number of drugs deemed essential and therefore subject to price caps to improve affordability, said people directly involved in the process.

24 Jun 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Motilal Oswal Securities Ltd.
$58.00
Provider: Axis Capital Limited
$35.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks